Next day disclosure return
Filed with HKEX · · 6 pages · English
Later from CF PharmTech
- Change in board lot size
- List of Directors and their Roles and Functions
- Voluntary announcement ICF004 completes enrolment and dosing of first healthy volunteer in phase i clinical trial
- 2026 Interim Report
- Voluntary announcement voluntary extension of lock-up period for shares held by core management by six months
Follow CF PharmTech into a list and get an email when it puts out news.
Follow CF PharmTech